GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Telcon RF Pharmaceutical 200230.KQ · KRW

Information Technology · KOSDAQ · 🇰🇷 South Korea

Compare

1,884

-1.00%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Telcon RF Pharmaceutical

Its shares trade on KOSDAQ under the ticker 200230.KQ. It has been listed since 24 November 2014. In the fiscal year to 31 December 2025, it reported revenue of ₩43.16bn and a net loss of ₩11.46bn. At that date it held total assets of ₩156.67bn and shareholders' equity of ₩108.50bn.

TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Listed since
24 Nov 2014

Leadership

Pay as last reported

  • Du Hyeon LeeChief Executive Officer, Director, since 2017
  • Chang Hyeon LeeDirector
  • Mr. Willis LeeDirector
  • Dr. Yutaka NiiharaDirector
  • Yeong Don SonNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Manufactures RF connectors and cable assemblies for wireless communication equipment.
  • Produces medicinal products alongside electrical equipment manufacturing.
  • Headquartered in Yongin, Gyeonggi-Do, Korea, supporting local market access.

Weaknesses

  • Limited to electrical equipment and medicinal product manufacturing segments.
  • Relies on RF connectors and cable assemblies as primary revenue sources.
  • IPO in 2014 may indicate limited market expansion since then.

Opportunities

  • Growing demand for wireless communication infrastructure in Korea.
  • Expansion into medicinal product markets with existing manufacturing capabilities.
  • Increased focus on electrical equipment in Information Technology sector.

Threats

  • Competition from global electrical equipment manufacturers in Korea.
  • Regulatory challenges in medicinal product distribution.
  • Economic fluctuations affecting Information Technology sector investments.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.